Track market-moving stories before they get noisy

Algert Global LLC decreased its position in Exponent, Inc. (NASDAQ:EXPO – Free Report) by 69.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 45,120 shares of the business services provider’s stock after selling 104,110 shares during the period. Algert Global LLC owned approximately 0.09% of Exponent worth $2,651,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of EXPO. Northwestern Mutual Wealth Management Co. boosted its holdings in Exponent by 87,479.8% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 230,335 shares of the business services provider’s stock valued at $15,999,000 after acquiring an additional 230,072 shares during the last quarter. UBS Group AG lifted its position in shares of Exponent by 29.7% in the 4th quarter. UBS Group AG now owns 176,404 shares of the business services provider’s stock worth $12,253,000 after purchasing an additional 40,359 shares during the period. Conestoga Capital Advisors LLC lifted its position in shares of Exponent by 1.3% in the 4th quarter. Conestoga Capital Advisors LLC now owns 2,392,499 shares of the business services provider’s stock worth $166,183,000 after purchasing an additional 31,303 shares during the period. Quantinno Capital Management LP lifted its position in shares of Exponent by 114.3% in the 1st quarter. Quantinno Capital Management LP now owns 36,614 shares of the business services provider’s stock worth $2,389,000 after purchasing an additional 19,528 shares during the period. Finally, New Age Alpha Advisors LLC boosted its stake in shares of Exponent by 785.8% in the 4th quarter. New Age Alpha Advisors LLC now owns 24,775 shares of the business services provider’s stock valued at $1,721,000 after purchasing an additional 21,978 shares during the last quarter. Institutional investors own 92.37% of the company’s stock.

Insider Buying and Selling at Exponent In other Exponent news, CEO Catherine Corrigan sold 1,707 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $66.28, for a total transaction of $113,139.96. Following the completion of the sale, the chief executive officer directly owned 129,108 shares of the company’s stock, valued at approximately $8,557,278.24. The trade was a 1.30% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.70% of the stock is owned by corporate insiders.

Analyst Ratings Changes A number of analysts have commented on the stock. JPMorgan Chase & Co. upped their price target on shares of Exponent from $80.00 to $90.00 and gave the company an “overweight” rating in a research report on Friday, July 31st. UBS Group set a $72.00 price objective on Exponent and gave the company a “neutral” rating in a research note on Friday, July 31st. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Exponent in a research report on Friday, July 17th. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $81.00. Get Our Latest Stock Report on Exponent

Exponent Stock Performance EXPO stock opened at $71.53 on Friday. The stock’s 50 day simple moving average is $64.33 and its 200 day simple moving average is $64.53. Exponent, Inc. has a fifty-two week low of $51.91 and a fifty-two week high of $81.95. The company has a market cap of $3.40 billion, a P/E ratio of 32.08 and a beta of 0.68.

Exponent (NASDAQ:EXPO – Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The business services provider reported $0.60 EPS for the quarter, beating analysts’ consensus estimates of $0.55 by $0.05. Exponent had a return on equity of 31.48% and a net margin of 17.67%.The firm had revenue of $171.61 million during the quarter, compared to analysts’ expectations of $144.99 million. During the same quarter last year, the firm posted $0.52 earnings per share. The company’s revenue for the quarter was up 12.0% compared to the same quarter last year. Equities analysts predict that Exponent, Inc. will post 2.31 earnings per share for the current year.

Exponent Announces Dividend The firm also recently announced a quarterly dividend, which will be paid on Friday, September 18th. Investors of record on Friday, September 4th will be issued a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Friday, September 4th. Exponent’s dividend payout ratio is currently 55.61%.

Exponent Profile (Free Report)

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.

Featured Stories Five stocks we like better than Exponent 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude? Okta Stock Surges 29%—Is $200 the Next Stop?

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.

Exponent (EXPO - Free Report) closed the last trading session at $66.85, gaining 9.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $84 indicates a 25.7% upside potential.

The mean estimate comprises three short-term price targets with a standard deviation of $10.39. While the lowest estimate of $72.00 indicates a 7.7% increase from the current price level, the most optimistic analyst expects the stock to surge 34.6% to reach $90.00. It's very important to note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.

While the consensus price target is a much-coveted metric for investors, solely banking on this metric to make an investment decision may not be wise at all. That's because the ability and unbiasedness of analysts in setting price targets have long been questionable.

However, an impressive consensus price target is not the only factor that indicates a potential upside in EXPO. This view is strengthened by the agreement among analysts that the company will report better earnings than what they estimated earlier. Though a positive trend in earnings estimate revisions doesn't give any idea as to how much the stock could surge, it has proven effective in predicting an upside.

Price, Consensus and EPS Surprise

Here's What You May Not Know About Analysts' Price TargetsAccording to researchers at several universities across the globe, a price target is one of many pieces of information about a stock that misleads investors far more often than it guides. In fact, empirical research shows that price targets set by several analysts, irrespective of the extent of agreement, rarely indicate where the price of a stock could actually be heading.

While Wall Street analysts have deep knowledge of a company's fundamentals and the sensitivity of its business to economic and industry issues, many of them tend to set overly optimistic price targets. Are you wondering why?

They usually do that to drum up interest in shares of companies that their firms either have existing business relationships with or are looking to be associated with. In other words, business incentives of firms covering a stock often result in inflated price targets set by analysts.

However, a tight clustering of price targets, which is represented by a low standard deviation, indicates that analysts have a high degree of agreement about the direction and magnitude of a stock's price movement. While that doesn't necessarily mean the stock will hit the average price target, it could be a good starting point for further research aimed at identifying the potential fundamental driving forces.

That said, while investors should not entirely ignore price targets, making an investment decision solely based on them could lead to disappointing ROI. So, price targets should always be treated with a high degree of skepticism.

Why EXPO Could Witness a Solid UpsideThere has been increasing optimism among analysts lately about the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher. And that could be a legitimate reason to expect an upside in the stock. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

The Zacks Consensus Estimate for the current year has increased 0.7% over the past month, as one estimate has gone higher compared to no negative revision.

Moreover, EXPO currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than 4,000 stocks that we rank based on four factors related to earnings estimates. Given an impressive externally-audited track record, this is a more conclusive indication of the stock's potential upside in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Therefore, while the consensus price target may not be a reliable indicator of how much EXPO could gain, the direction of price movement it implies does appear to be a good guide.

Exponent (EXPO - Free Report) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.52 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +9.09%. A quarter ago, it was expected that this engineering and scientific consulting company would post earnings of $0.56 per share when it actually produced earnings of $0.59, delivering a surprise of +5.36%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Exponent, which belongs to the Zacks Consulting Services industry, posted revenues of $148.86 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 3.34%. This compares to year-ago revenues of $132.87 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Exponent shares have lost about 5.2% since the beginning of the year versus the S&P 500's gain of 6.9%.

What's Next for Exponent?While Exponent has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Exponent was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.60 on $146.92 million in revenues for the coming quarter and $2.28 on $586.57 million in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Consulting Services is currently in the top 38% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, Information Services Group (III - Free Report) , has yet to report results for the quarter ended June 2026. The results are expected to be released on August 5.

This market advisory service company is expected to post quarterly earnings of $0.09 per share in its upcoming report, which represents a year-over-year change of +12.5%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Information Services Group's revenues are expected to be $62.75 million, up 1.9% from the year-ago quarter.

MENLO PARK, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the second quarter of fiscal year 2026 ended July 3, 2026.

“Exponent delivered another strong quarter, with double-digit growth in revenues and earnings reflecting continued demand for our specialized expertise across industries,” stated Dr. Catherine Corrigan, Chief Executive Officer. “Our proactive work experienced strong growth in the quarter, led by demand for user research studies as clients accelerate the development of AI-enabled products across an increasingly diverse range of hardware form factors and applications, with engagements continuing to expand in scope, scale and complexity. Proactive activity was also supported by increased risk management and infrastructure-related engagements in the utility sector. Reactive work grew, with strong demand for our dispute-related expertise from the consumer products, chemicals, and transportation industries.

“These results reflect the powerful long-term trends driving our business, including rapid technological innovation, increasing complexity, growing energy demand, investment in resilient power and digital infrastructure, and rising expectations for safety, reliability, and performance. As artificial intelligence becomes embedded in an expanding array of physical products and systems, organizations face increasingly daunting human factors, operational, and risk management challenges that extend well beyond software. Clients turn to Exponent when they encounter critical questions involving the interaction of technology, people, and complex real-world environments, particularly when the consequences of failure are exceptionally high. Our multidisciplinary teams provide the independent, science-based insights needed to accelerate innovation, improve decision-making, and reduce high-consequence risk in areas where few organizations possess comparable expertise,” Dr. Corrigan continued.

Second Quarter Financial Results

Total revenues and revenues before reimbursements for the second quarter of 2026 increased 21% to $171.6 million and 12% to $148.9 million, respectively, as compared to $142.0 million and $132.9 million in the second quarter of 2025.

Net income increased to $29.4 million, or $0.60 per diluted share, in the second quarter of 2026, as compared to $26.6 million, or $0.52 per diluted share, in the same period of 2025. The tax impact associated with share-based awards was immaterial in both the second quarter of 2026 and 2025. Exponent’s consolidated tax rate was 27.9% in the second quarter of 2026, unchanged from the same period in 2025.

EBITDA1 increased to $42.7 million, or 28.7% of revenues before reimbursements, in the second quarter of 2026, as compared to $37.0 million, or 27.8% of revenues before reimbursements in the second quarter of 2025.

Year-to-Date Financial Results

Total revenues and revenues before reimbursements for the first half of 2026 increased 18% to $337.9 million and 11% to $300.7 million, respectively, as compared to $287.5 million and $270.3 million in the same period of 2025.

Net income increased to $59.0 million, or $1.19 per diluted share, in the first half of 2026, as compared to $53.2 million, or $1.03 per diluted share, in the same period of 2025. During the first half of 2026, we realized a negative tax impact associated with share-based awards of $0.8 million as compared to $0.5 million in the first half of 2025. Inclusive of the tax impact associated with share-based awards, Exponent’s consolidated tax rate was 29.0% in the first half of 2026, as compared to 28.7% for the same period last year.

EBITDA1 increased to $85.9 million, or 28.6% of revenues before reimbursements, in the first half of 2026, as compared to $74.5 million, or 27.6% of revenues before reimbursements, in the first half of 2025.

For the first half of 2026, Exponent paid $31.3 million in dividends, repurchased $146.1 million of common stock, and closed the period with $66.6 million in cash and cash equivalents.

In a separate press release today, Exponent announced its quarterly cash dividend of $0.31 to be paid on September 18, 2026, and reiterated its intent to continue to pay quarterly dividends. Additionally, Exponent’s Board of Directors approved an increase in the current stock repurchase program of $50 million.

Business Overview

Exponent’s engineering and other scientific segment represented 85% of the Company’s revenues before reimbursements in the second quarter and through the first two quarters of 2026. Revenues before reimbursements in this segment increased 13% during the second quarter and 12% during the first half of 2026, as compared to the prior year period. Growth during the quarter was driven by strong user research activity in consumer electronics, risk management and infrastructure-related work in the utilities sector, and reactive engagements across the consumer products, chemicals, and transportation industries.

Exponent’s environmental and health segment represented 15% of the Company’s revenues before reimbursements in the second quarter and through the first two quarters of 2026. Revenues before reimbursements in this segment increased 9% during the second quarter and 5% during the first half of 2026, as compared to the same period in the prior year. Growth during the quarter was driven by engagements evaluating the impacts of chemicals on human health and the environment.

Business Outlook

“Our second quarter results demonstrate continued disciplined execution across the business, with strong utilization of 74% contributing to performance that exceeded our expectations,” commented Eric Anderson, Chief Financial Officer. “We continued to invest in our talent and capabilities while maintaining a disciplined capital allocation strategy, returning a combined $272 million to shareholders over the last twelve months through share repurchases and our ongoing dividend program.”

For the third quarter of fiscal 2026 as compared to the same period one year prior, Exponent anticipates:

Revenues before reimbursements to grow 8% to 10%; and,EBITDA1 to be 28.0% to 28.5% of revenues before reimbursements. For the full fiscal year 2026 as compared to fiscal year 2025, Exponent is raising its revenue and margin guidance, anticipating:

Revenues before reimbursements to grow 9% to 10%; and,EBITDA1 to be 27.8% to 28.1% of revenues before reimbursements. “Exponent remains well positioned to support clients as emerging technologies, critical infrastructure, and increasingly complex and interconnected systems reshape industries around the world,” Dr. Corrigan said. “Whether helping clients evaluate AI-enabled products, enhancing the resilience and performance of infrastructure, or navigating complex technical and regulatory challenges, our expert ecosystem provides the rigorous, independent insights needed when the stakes are high. We remain confident in our ability to expand our impact across industries and deliver long-term value for our shareholders.”

Today’s Conference Call Information

Exponent will discuss its financial results in more detail on a conference call today, Thursday, July 30, 2026, starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time. The audio of the conference call is available by dialing (844) 481-2781 or (412) 317-0672. A live webcast of the call will be available on the Investor Relations section of the Company’s website at www.exponent.com/investors. For those unable to listen to the live webcast, a replay of the call will also be available on the Exponent website, or by dialing (855) 669-9658 or (412) 317-0088 and entering passcode 7563057#.

Use of non-GAAP Financial Measures 1

EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation, and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income, and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present, and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance, financial position, or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP.

Exponent has provided its outlook regarding EBITDA as a percentage of revenues before reimbursements. The Company has not reconciled this non-GAAP financial measure to the corresponding GAAP financial measure because guidance for the various reconciling items is not provided and the Company is unable to estimate with reasonable certainty the effect of these items without unreasonable effort. For example, the Company is unable to estimate with reasonable certainty the impact of equity awards on Exponent’s taxes without unreasonable effort. These items are uncertain, depend on various factors, and may have a material effect on Exponent’s results computed in accordance with GAAP. A reconciliation between the historical GAAP and non-GAAP financial measures presented in this release is provided in the financial tables at the end of this release.

About Exponent

Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.

Exponent’s consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent’s offices in North America, Asia, and Europe. Exponent’s consultants, laboratories, and integrated technical platform work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward at speed.

Exponent may be reached at (888) 656­-EXPO, [email protected], or www.exponent.com.

Forward Looking Statements

This news release contains, and incorporates by reference, certain “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended) that are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. When used in this document and in the documents incorporated herein by reference, the words “intend,” “anticipate,” “believe,” “estimate,” “expect” and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in generally applicable and industry-specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading “Risk Factors” and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.

Source: Exponent, Inc.

 EXPONENT, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
For the Three and Six Months Ended July 3, 2026 and July 4, 2025
(unaudited)
(in thousands, except per share data)
                         Quarter Ended
 Six Months Ended
   July 3,
 July 4,
 July 3,
 July 4,
   2026
 2025
 2026
 2025
              Revenues            Revenues before reimbursements$148,860  $132,868  $300,677  $270,305  Reimbursements 22,752   9,094   37,238   17,164                 Revenues 171,612   141,962   337,915   287,469               Operating expenses            Compensation and related expenses 100,571   97,474   191,980   173,377  Other operating expenses 12,865   12,072   25,690   24,167  Reimbursable expenses 22,752   9,094   37,238   17,164  General and administrative expenses 7,402   6,145   13,606   11,152                   143,590   124,785   268,514   225,860                 Operating income 28,022   17,177   69,401   61,609               Other income            Interest income, net 716   2,344   2,434   5,058  Miscellaneous income (expense), net 12,028   17,294   11,270   7,908     12,744   19,638   13,704   12,966                 Income before income taxes 40,766   36,815   83,105   74,575               Income taxes 11,371   10,262   24,141   21,372                               Net income$29,395  $26,553  $58,964  $53,203                             Net income per share:            Basic$0.60  $0.52  $1.20  $1.04  Diluted$0.60  $0.52  $1.19  $1.03               Shares used in per share computations:            Basic 48,753   51,185   49,271   51,234  Diluted 48,987   51,502   49,571   51,587                 EXPONENT, INC.CONDENSED CONSOLIDATED BALANCE SHEETSJuly 3, 2026 and January 2, 2026(unaudited)(in thousands)                  July 3, January 2,    2026
 2026
   Assets   Current assets:
    Cash and cash equivalents$66,629  $221,930  Accounts receivable, net 218,504   181,507  Prepaid expenses and other assets 26,881   24,143   Total current assets 312,014   427,580 Property, equipment and leasehold improvements, net 70,854   71,981 Operating lease right-of-use asset 68,954   73,376 Goodwill
 8,607   8,607 Other assets
 192,294   195,975     $652,723  $777,519           Liabilities and Stockholders' Equity   Current liabilities:    Accounts payable and accrued liabilities$26,942  $30,942  Accrued payroll and employee benefits 102,186   121,302  Deferred revenues 21,953   18,868  Operating lease liability 6,757   6,890   Total current liabilities 157,838   178,002 Other liabilities
 132,305   133,232 Operating lease liability 73,964   75,944   Total liabilities 364,107   387,178        Stockholders' equity:    Common stock 66   66  Additional paid-in capital 389,568   369,747  Accumulated other comprehensive loss (2,378)  (2,290) Retained earnings 696,405   668,423  Treasury stock, at cost (795,045)  (645,605)   Total stockholders' equity 288,616   390,341     $652,723  $777,519          EXPONENT, INC.EBITDA and EBITDAS (1)For the Three and Six Months Ended July 3, 2026 and July 4, 2025(unaudited)(in thousands)                   Quarter Ended Six Months Ended   July 3, July 4, July 3, July 4,   2026
 2025
 2026
 2025
          Net Income$29,395  $26,553  $58,964  $53,203           Add back (subtract):                  Income taxes 11,371   10,262   24,141   21,372  Interest income, net (716)  (2,344)  (2,434)  (5,058) Depreciation and amortization 2,678   2,520   5,193   5,012             EBITDA (1) 42,728   36,991   85,864   74,529            Stock-based compensation 6,680   5,246   15,738   13,426             EBITDAS (1)$49,408  $42,237  $101,602  $87,955                               (1) EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP.          

July 09, 2026 17:30 ET  | Source: Exponent, Inc.

MENLO PARK, Calif., July 09, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report Second Quarter of fiscal year 2026 financial results for the period ended July 3, 2026 following the close of the market on Thursday, July 30, 2026. On that day, Chief Executive Officer Dr. Catherine Corrigan, President John Pye, Executive Vice President Richard Schlenker, and Chief Financial Officer Eric Anderson, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company’s business and financial results.

Event:Exponent, Inc. Second Quarter of Fiscal Year 2026 Financial Results Conference CallDate:Thursday, July 30, 2026Time:4:30 p.m. Eastern Time / 1:30 p.m. Pacific TimeLive Call:(844) 481-2781 or (412) 317-0672   Exponent will also offer a live and archived webcast of the conference call, accessible from the Investor Relations section of the company's website, http://www.exponent.com/investors. A telephonic replay of the conference call will be available until Thursday, August 6, 2026 by dialing (855) 669-9658 or (412) 317-0088 and entering passcode 7563057#.

About Exponent

Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.

Exponent's consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent's offices in North America, Asia, and Europe. Exponent's consultants, laboratories, databases, and computing resources work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward. 

Exponent may be reached at (888) 656-EXPO, [email protected], or www.exponent.com.

Company to showcase differentiated scientific and engineering capabilities, multidisciplinary expertise, and innovation-driven growth strategy June 17, 2026 16:05 ET  | Source: Exponent, Inc.

MENLO PARK, Calif., June 17, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), a leading engineering and scientific consulting firm, today announced that it will host an Investor Day at the Company’s Phoenix Test & Engineering Center on September 29, 2026, beginning at 8:30 a.m. Pacific Time.

The half-day event will feature presentations from Exponent’s executive leadership team and key market leaders, highlighting the Company’s premium service offerings, bespoke multidisciplinary solutions, and growth opportunities driven by rapid innovation, rising expectations for safety and performance, and unprecedented capital deployment into AI infrastructure.

Attendees will also tour Exponent’s Phoenix Test & Engineering Center and experience firsthand the Company’s advanced testing, failure analysis, and engineering capabilities through live demonstrations. The tour will showcase how Exponent helps clients address complex challenges at the intersection of hardware, software, AI-enabled systems, and human behavior – particularly where safety, reliability, and performance are critical.

“Our Investor Day will provide an opportunity to showcase the expertise, technical rigor, and collaborative culture that have made Exponent a trusted advisor to many of the world’s leading companies,” said Dr. Catherine Corrigan, Chief Executive Officer of Exponent. “As artificial intelligence and other emerging technologies become increasingly embedded within physical products, infrastructure, and critical systems, we see expanding opportunities for Exponent’s multidisciplinary expertise to support safety, reliability, performance, and risk mitigation. We look forward to highlighting how Exponent is uniquely positioned to support clients as innovation accelerates and system complexity grows.”

The program will highlight several key elements of Exponent’s differentiated model, including:

A uniquely multidisciplinary platform spanning more than 90 technical disciplines, enabling the firm to address highly complex, high-stakes engineering and scientific challengesDeep technical expertise and independent scientific analysis supporting mission critical decision-makingIndustry-leading capabilities in failure analysis, testing, reliability, and risk assessment for complex products and systemsExposure to long-term secular growth trends including AI and machine learning, autonomous systems, robotics, advanced consumer electronics, medical devices, energy, and data centers “Exponent’s value proposition is grounded in scientific excellence, independence, and the ability to solve problems that few organizations are equipped to address,” said Dr. John Pye, President of Exponent. “We look forward to giving investors an inside view into the expertise, infrastructure, and innovation that will continue to drive our long-term growth.”

Additional details, including registration information, will be provided closer to the event date.

About Exponent

Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.

Exponent’s consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent’s offices in North America, Asia, and Europe. Exponent’s consultants, laboratories, and integrated technical platform work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward at speed.

Exponent may be reached at (888) 656-EXPO, [email protected], or www.exponent.com.

After years of demand, the beloved color returns, powered by EXPO's new vibrant ink technology in time for the brand's 50th anniversary.

, /PRNewswire/ -- The EXPO® Yellow Dry Erase Marker, part of the Newell Brands portfolio, is back and brighter than ever. After years of requests from educators, organizers and longtime fans, the iconic shade is officially returning to the lineup following the introduction of EXPO's vibrant ink technology in 2025.

Back by Popular Demand: EXPO Reintroduces Its Iconic Yellow Dry Erase Marker

Designed for bold visibility and smooth, consistent performance, EXPO Yellow features the brand’s most vibrant ink yet. Yellow has historically been one of the most challenging colors for dry erase markers because it must be bright enough to stand out clearly on writing surfaces. With advances in EXPO's ink technology, Newell's Research and Development team enhanced the formula, so Yellow now pops on whiteboards and clear surfaces like windows.

"Yellow is a color consumers have asked us to bring back again and again," said Kris Malkoski, President, Learning & Development, Newell. "Teachers often use yellow to draw the sun and office workers gravitate to it to highlight key ideas on the board. With EXPO's vibrant ink innovation, we're excited to bring Yellow back with a bold, highly visible ink designed to stand out."

Since its discontinuation nearly two decades ago, EXPO Yellow has remained a nostalgic favorite among teachers and students who remember it as a staple of classroom color-coding systems and as a cheerful pop of color during lessons. Over the years, hundreds of consumers have asked for its return and kept the conversation alive on social media. Creators like TikToker @teachwithmx.ram, whose videos celebrate classic classroom tools, helped reignite conversation around the return of EXPO Yellow.

The return of the coveted yellow hue is powered by EXPO's new vibrant ink, introduced in 2025 across the full dry erase marker line. The improved ink delivers brighter, more saturated color designed to increase visibility on whiteboards, clear surfaces like glass, and other non-porous surfaces, making writing easier to read from a distance.

EXPO has been a partner in organizing ideas, teaching lessons, and planning everyday life for 50 years and continues to do that by listening to the people who use it most and introducing solutions to make the complicated, simple – and the simple, inspiring.

Availability
EXPO Yellow Dry Erase Markers are available now at Target and will be available at major retailers including Amazon, Walmart, Office Depot and Staples in the coming weeks. Yellow is available in both Fine Tip and Chisel Tip across various color assortments and pack sizes, including:

EXPO Dry Erase Fine Tip 12ct Assorted – Starting at $13.49 EDLP EXPO Dry Erase Chisel Tip 21ct Assorted – Starting at $21.99 EDLP EXPO Dry Erase Fine Tip 21ct Assorted – Starting at $21.99 EDLP About EXPO®
EXPO® is America's leading brand of dry and wet erase markers, trusted by teachers, professionals, parents, and creatives for bold color, clean erasing, and reliable performance. Designed to help people stay in control, EXPO products are Made for Change™ to keep ideas and plans flexible. EXPO is part of the Newell Brands global portfolio of leading brands.

About Newell Brands
Newell Brands (NASDAQ: NWL) is a leading global consumer goods company with a strong portfolio of well-known brands, including Rubbermaid, Sharpie®, Graco®, Coleman®, Rubbermaid Commercial Products®, Yankee Candle®, Paper Mate®, FoodSaver®, Dymo®, EXPO®, Elmer's®, Oster®, NUK®, Spontex® and Campingaz®. Newell Brands is focused on delighting consumers by lighting up everyday moments.

SOURCE Newell Brands

Posted by Defense World Staff on Apr 4th, 2026

SG Americas Securities LLC raised its position in shares of Exponent, Inc. (NASDAQ:EXPO – Free Report) by 422.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 36,610 shares of the business services provider’s stock after purchasing an additional 29,600 shares during the quarter. SG Americas Securities LLC owned 0.07% of Exponent worth $2,543,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in EXPO. Hantz Financial Services Inc. boosted its holdings in shares of Exponent by 97.0% in the third quarter. Hantz Financial Services Inc. now owns 396 shares of the business services provider’s stock worth $28,000 after buying an additional 195 shares during the last quarter. Aster Capital Management DIFC Ltd purchased a new stake in Exponent during the third quarter valued at approximately $33,000. Winnow Wealth LLC purchased a new stake in Exponent during the third quarter valued at approximately $34,000. Pilgrim Partners Asia Pte Ltd bought a new position in Exponent in the third quarter worth approximately $38,000. Finally, GAMMA Investing LLC raised its position in Exponent by 50.4% in the fourth quarter. GAMMA Investing LLC now owns 576 shares of the business services provider’s stock worth $40,000 after acquiring an additional 193 shares during the period. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Exponent Price Performance Shares of NASDAQ:EXPO opened at $66.56 on Friday. The company has a market capitalization of $3.28 billion, a P/E ratio of 32.00 and a beta of 0.80. Exponent, Inc. has a 1-year low of $63.25 and a 1-year high of $83.92. The firm’s 50 day simple moving average is $69.86 and its two-hundred day simple moving average is $70.47.

Exponent (NASDAQ:EXPO – Get Free Report) last announced its quarterly earnings data on Thursday, February 5th. The business services provider reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.47 by $0.02. Exponent had a net margin of 18.21% and a return on equity of 25.51%. The firm had revenue of $147.43 million during the quarter, compared to analysts’ expectations of $128.48 million. During the same period in the prior year, the company posted $0.46 earnings per share. The company’s revenue for the quarter was up 4.5% compared to the same quarter last year. On average, sell-side analysts anticipate that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.

Exponent Increases Dividend The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Friday, March 6th were given a $0.31 dividend. The ex-dividend date was Friday, March 6th. This is a positive change from Exponent’s previous quarterly dividend of $0.30. This represents a $1.24 annualized dividend and a dividend yield of 1.9%. Exponent’s dividend payout ratio (DPR) is presently 59.62%.

Insider Transactions at Exponent In related news, CEO Catherine Corrigan sold 3,920 shares of the stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $67.15, for a total transaction of $263,228.00. Following the completion of the sale, the chief executive officer owned 93,731 shares in the company, valued at approximately $6,294,036.65. This trade represents a 4.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP John Pye sold 4,000 shares of Exponent stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $75.97, for a total value of $303,880.00. Following the sale, the vice president directly owned 25,204 shares in the company, valued at $1,914,747.88. This trade represents a 13.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 9,583 shares of company stock valued at $687,709. Corporate insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets A number of brokerages have recently issued reports on EXPO. JPMorgan Chase & Co. cut their price objective on shares of Exponent from $100.00 to $95.00 and set an “overweight” rating for the company in a research report on Thursday, March 26th. UBS Group reiterated a “neutral” rating and set a $85.00 target price on shares of Exponent in a research report on Monday, February 9th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Exponent in a report on Thursday, January 22nd. Two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, Exponent currently has a consensus rating of “Moderate Buy” and an average price target of $90.00.

Check Out Our Latest Analysis on Exponent

Exponent Profile (Free Report)

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.

Read More Five stocks we like better than Exponent

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAmerican Financial Group, Inc. $AFG Shares Bought by SG Americas Securities LLC

NEXT HEADLINE »Global X Japan Co. Ltd. Has $90.55 Million Stock Holdings in NVIDIA Corporation $NVDA

April 09, 2026 16:05 ET  | Source: Exponent, Inc.

MENLO PARK, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report First Quarter of fiscal year 2026 financial results for the period ended April 3, 2026 following the close of the market on Thursday, April 30, 2026. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company’s business and financial results.

Event:Exponent, Inc. First Quarter of Fiscal Year 2026 Financial Results Conference CallDate:Thursday, April 30, 2026Time:4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time Live Call:(844) 481-2781 or (412) 317-0672   Exponent will also offer a live and archived webcast of the conference call, accessible from the Investor Relations section of the company's website, http://www.exponent.com/investors. A telephonic replay of the conference call will be available until Thursday, May 7, 2026 by dialing (855) 669-9658 or (412) 317-0088 and entering passcode 4146822#. 

About Exponent

Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.

Exponent's consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent's offices in North America, Asia, and Europe. Exponent's consultants, laboratories, databases, and computing resources work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward.

Exponent may be reached at (888) 656-EXPO, [email protected], or www.exponent.com.

Posted by Defense World Staff on Apr 23rd, 2026

Exponent (NASDAQ:EXPO – Get Free Report) is expected to be issuing its Q1 2026 results after the market closes on Thursday, April 30th. Analysts expect the company to announce earnings of $0.56 per share and revenue of $149.5290 million for the quarter. Interested persons can check the company’s upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Thursday, April 30, 2026 at 4:30 PM ET.

Exponent (NASDAQ:EXPO – Get Free Report) last released its quarterly earnings results on Thursday, February 5th. The business services provider reported $0.49 EPS for the quarter, beating the consensus estimate of $0.47 by $0.02. Exponent had a net margin of 18.21% and a return on equity of 25.51%. The business had revenue of $147.43 million during the quarter, compared to analyst estimates of $128.48 million. During the same period in the prior year, the firm posted $0.46 earnings per share. The company’s quarterly revenue was up 4.5% on a year-over-year basis. On average, analysts expect Exponent to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Exponent Stock Performance NASDAQ:EXPO opened at $67.56 on Thursday. The company’s 50-day simple moving average is $68.19 and its 200-day simple moving average is $70.30. Exponent has a fifty-two week low of $63.25 and a fifty-two week high of $83.92. The stock has a market capitalization of $3.28 billion, a P/E ratio of 32.48 and a beta of 0.80.

Exponent Increases Dividend The company also recently announced a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Friday, March 6th were given a dividend of $0.31 per share. The ex-dividend date of this dividend was Friday, March 6th. This is a positive change from Exponent’s previous quarterly dividend of $0.30. This represents a $1.24 dividend on an annualized basis and a yield of 1.8%. Exponent’s dividend payout ratio is currently 59.62%.

Wall Street Analysts Forecast Growth Several equities analysts have issued reports on the stock. JPMorgan Chase & Co. cut their price target on shares of Exponent from $100.00 to $95.00 and set an “overweight” rating on the stock in a report on Thursday, March 26th. Weiss Ratings restated a “hold (c-)” rating on shares of Exponent in a research note on Thursday, January 22nd. Finally, UBS Group reiterated a “neutral” rating and issued a $85.00 price target on shares of Exponent in a research note on Monday, February 9th. Two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, Exponent currently has an average rating of “Moderate Buy” and a consensus target price of $90.00.

Get Our Latest Research Report on EXPO

Insider Buying and Selling at Exponent In related news, VP John Pye sold 4,000 shares of the firm’s stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $75.97, for a total value of $303,880.00. Following the completion of the transaction, the vice president owned 25,204 shares in the company, valued at $1,914,747.88. This trade represents a 13.70% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Catherine Corrigan sold 3,909 shares of the business’s stock in a transaction dated Wednesday, April 15th. The shares were sold at an average price of $67.70, for a total value of $264,639.30. Following the sale, the chief executive officer owned 103,676 shares in the company, valued at approximately $7,018,865.20. The trade was a 3.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 15,741 shares of company stock valued at $1,095,768 over the last quarter. Insiders own 1.60% of the company’s stock.

Institutional Investors Weigh In On Exponent A number of institutional investors and hedge funds have recently modified their holdings of the company. United Services Automobile Association purchased a new position in Exponent during the 1st quarter worth approximately $270,000. Jane Street Group LLC increased its stake in shares of Exponent by 1,481.0% in the first quarter. Jane Street Group LLC now owns 127,222 shares of the business services provider’s stock worth $10,313,000 after acquiring an additional 119,175 shares during the period. Invesco Ltd. increased its stake in shares of Exponent by 3.3% in the second quarter. Invesco Ltd. now owns 554,733 shares of the business services provider’s stock worth $41,444,000 after acquiring an additional 17,930 shares during the period. First Trust Advisors LP purchased a new position in shares of Exponent during the second quarter worth $18,377,000. Finally, Walleye Capital LLC raised its holdings in shares of Exponent by 7.5% during the second quarter. Walleye Capital LLC now owns 6,623 shares of the business services provider’s stock worth $495,000 after purchasing an additional 464 shares during the last quarter. Institutional investors and hedge funds own 92.37% of the company’s stock.

About Exponent (Get Free Report)

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.

Further Reading Five stocks we like better than Exponent

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEArrow Electronics (ARW) to Release Quarterly Earnings on Thursday

NEXT HEADLINE »Mohawk Industries (MHK) Projected to Post Earnings on Thursday

Posted by Defense World Staff on Apr 25th, 2026

Evergreen Capital Management LLC purchased a new stake in shares of Exponent, Inc. (NASDAQ:EXPO – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 11,081 shares of the business services provider’s stock, valued at approximately $770,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. HM Payson & Co. increased its position in shares of Exponent by 33.9% during the 3rd quarter. HM Payson & Co. now owns 589 shares of the business services provider’s stock valued at $41,000 after purchasing an additional 149 shares during the last quarter. Arizona State Retirement System increased its position in shares of Exponent by 1.1% during the 3rd quarter. Arizona State Retirement System now owns 14,984 shares of the business services provider’s stock valued at $1,041,000 after purchasing an additional 162 shares during the last quarter. GAMMA Investing LLC increased its position in shares of Exponent by 50.4% during the 4th quarter. GAMMA Investing LLC now owns 576 shares of the business services provider’s stock valued at $40,000 after purchasing an additional 193 shares during the last quarter. Hantz Financial Services Inc. increased its position in shares of Exponent by 97.0% during the 3rd quarter. Hantz Financial Services Inc. now owns 396 shares of the business services provider’s stock valued at $28,000 after purchasing an additional 195 shares during the last quarter. Finally, Orion Porfolio Solutions LLC increased its position in shares of Exponent by 2.6% during the 2nd quarter. Orion Porfolio Solutions LLC now owns 8,525 shares of the business services provider’s stock valued at $637,000 after purchasing an additional 219 shares during the last quarter. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Exponent Price Performance Shares of EXPO opened at $65.88 on Friday. Exponent, Inc. has a 1 year low of $63.25 and a 1 year high of $81.95. The company has a 50 day simple moving average of $68.15 and a two-hundred day simple moving average of $70.27. The firm has a market cap of $3.20 billion, a P/E ratio of 31.67 and a beta of 0.80.

Exponent (NASDAQ:EXPO – Get Free Report) last announced its quarterly earnings data on Thursday, February 5th. The business services provider reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.47 by $0.02. Exponent had a net margin of 18.21% and a return on equity of 25.51%. The business had revenue of $147.43 million during the quarter, compared to analyst estimates of $128.48 million. During the same period last year, the firm posted $0.46 EPS. The company’s revenue was up 4.5% on a year-over-year basis. On average, sell-side analysts anticipate that Exponent, Inc. will post 2.27 earnings per share for the current year.

Exponent Increases Dividend The business also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Friday, March 6th were issued a dividend of $0.31 per share. This is an increase from Exponent’s previous quarterly dividend of $0.30. The ex-dividend date of this dividend was Friday, March 6th. This represents a $1.24 dividend on an annualized basis and a yield of 1.9%. Exponent’s payout ratio is 59.62%.

Analyst Upgrades and Downgrades EXPO has been the subject of several analyst reports. JPMorgan Chase & Co. reduced their target price on shares of Exponent from $100.00 to $95.00 and set an “overweight” rating for the company in a report on Thursday, March 26th. UBS Group reissued a “neutral” rating and issued a $85.00 target price on shares of Exponent in a report on Monday, February 9th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Exponent in a report on Tuesday. Two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $90.00.

View Our Latest Stock Report on Exponent

Insider Buying and Selling In other Exponent news, CEO Catherine Corrigan sold 3,909 shares of the stock in a transaction that occurred on Wednesday, April 15th. The shares were sold at an average price of $67.70, for a total transaction of $264,639.30. Following the completion of the sale, the chief executive officer directly owned 103,676 shares of the company’s stock, valued at $7,018,865.20. This trade represents a 3.63% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP John Pye sold 4,000 shares of the stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $75.97, for a total transaction of $303,880.00. Following the sale, the vice president directly owned 25,204 shares of the company’s stock, valued at approximately $1,914,747.88. This trade represents a 13.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 15,741 shares of company stock valued at $1,095,768. Insiders own 1.60% of the company’s stock.

Exponent Company Profile (Free Report)

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.

See Also Five stocks we like better than Exponent Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO – Free Report).

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEON Semiconductor Corporation $ON Shares Purchased by Evergreen Capital Management LLC

NEXT HEADLINE »Allison Transmission Holdings, Inc. $ALSN Shares Acquired by Caprock Group LLC

MENLO PARK, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2026 ended April 3, 2026.

“Exponent delivered double-digit growth in revenues and earnings during the first quarter, reflecting the strength of our multidisciplinary portfolio and increased demand for our specialized expertise across industries,” stated Dr. Catherine Corrigan, President and Chief Executive Officer. “Growth was driven by proactive engagements, including user research studies for consumer electronics clients integrating AI into their devices, as well as risk management work for utility clients evaluating asset performance under extreme weather conditions. Reactive engagements also contributed to our growth, with increased dispute-related and failure analysis demand across construction projects, energy facilities, and medical devices.

“The integration of AI and other advanced technologies into physical products and performance-critical systems, combined with rising expectations for safety and reliability, is driving increased reliance on Exponent’s specialized expertise. At the same time, trends in energy demand, infrastructure risk, and innovation continue to support demand for our deep technical capabilities, reinforcing our essential role in helping clients navigate complex, high-stakes decisions,” Dr. Corrigan continued.

First Quarter Financial Results

Total revenues and revenues before reimbursements for the first quarter of 2026 increased 14% to $166.3 million and 10% to $151.8 million, respectively, as compared to $145.5 million and $137.4 million in the first quarter of 2025.

Net income increased to $29.6 million, or $0.59 per diluted share, in the first quarter of 2026, as compared to $26.7 million, or $0.52 per diluted share, in the same period of 2025. During the quarter, Exponent realized a negative tax impact associated with share-based awards of $0.9 million as compared to $0.5 million in the first quarter of 2025. Inclusive of the negative tax impact, Exponent's consolidated tax rate was 30.2% in the first quarter, as compared to 29.4% for the same period in 2025.

EBITDA1 increased to $43.1 million, or 28.4% of net revenues, in the first quarter of 2026, as compared to $37.5 million, or 27.3% of net revenues in the first quarter of 2025.

During the first quarter of 2026, Exponent paid $16.6 million in dividends, repurchased $78.8 million of common stock, and closed the period with $118.6 million in cash and cash equivalents.

In a separate press release today, Exponent announced its quarterly cash dividend of $0.31 to be paid on June 18, 2026, and reiterated its intent to continue to pay quarterly dividends. Additionally, Exponent’s Board of Directors approved an increase in the current stock repurchase program of $50 million. This is in addition to the $17.7 million available for repurchases as of April 3, 2026. 

Business Overview

Exponent’s engineering and other scientific segment represented 85% of the Company’s revenues before reimbursements in the first quarter of 2026. Revenues before reimbursements in this segment increased 12% in the first quarter, compared to the prior year period. Growth during the quarter was driven by user research studies in consumer electronics and risk management in the utilities sector, along with reactive engagements in the energy and life sciences sectors.

Exponent’s environmental and health segment represented 15% of the Company’s revenues before reimbursements in the first quarter. Revenues before reimbursements in this segment increased 2% in the first quarter, compared to the prior year period. Growth in this segment was primarily driven by Exponent’s regulatory consulting in the chemical industry.

Business Outlook

“Exponent delivered a strong first quarter, with 5% year-over-year headcount growth, 76% utilization, and strong rate realization driving growth,” commented Richard Schlenker, Executive Vice President and Chief Financial Officer. “We are encouraged by the market opportunities and remain confident in the long-term growth trajectory of the business.”

For the second quarter of fiscal 2026 as compared to the same period one year prior, Exponent anticipates:

Revenues before reimbursements to grow in the high-single digits; and,EBITDA1 to be 27.0% to 27.8% of revenues before reimbursements. For the full fiscal year 2026 as compared to fiscal year 2025, Exponent is maintaining its guidance and anticipates:

Revenues before reimbursements to grow in the high-single digits; and,EBITDA1 to be 27.6% to 28.1% of revenues before reimbursements. “Exponent is well positioned to support the evolving needs of our clients as innovation accelerates and systems grow more complex, particularly as AI is increasingly embedded in the physical world,” Dr. Corrigan said. “These dynamics continue to drive demand for our differentiated multidisciplinary expertise, independent evaluation, and trusted insight.

“Our recent leadership evolution further strengthens our ability to capitalize on these opportunities,” Dr. Corrigan continued. John Pye brings visionary leadership and a proven track record of innovation, playing a key role in advancing our capabilities while remaining firmly grounded in the technical rigor and independence that define Exponent. Eric Anderson adds deep financial and operational expertise, along with a strong understanding of our business and strategy. Rich Schlenker will continue to serve as Executive Vice President and has been nominated for election to the Board of Directors. Supported by our exceptional talent and distinct position in the marketplace, Exponent is well positioned to build on our momentum and deliver long-term value for our clients and shareholders.”

Today's Conference Call Information

Exponent will discuss its financial results in more detail on a conference call today, Thursday, April 30, 2026, starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time. The audio of the conference call is available by dialing (844) 481-2781 or (412) 317-0672. A live webcast of the call will be available on the Investor Relations section of the Company's website at www.exponent.com/investors. For those unable to listen to the live webcast, a replay of the call will also be available on the Exponent website, or by dialing (855) 669-9658 or (412) 317-0088 and entering passcode 4146822#.

Use of non-GAAP Financial Measures 1

EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation, and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income, and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present, and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position, or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP.

Exponent has provided its outlook regarding EBITDA as a percentage of revenues before reimbursements. The Company has not reconciled this non-GAAP financial measure to the corresponding GAAP financial measure because guidance for the various reconciling items is not provided and the Company is unable to estimate with reasonable certainty the effect of these items without unreasonable effort. For example, the Company is unable to estimate with reasonable certainty the impact of equity awards on Exponent’s taxes without unreasonable effort. These items are uncertain, depend on various factors, and may have a material effect on Exponent’s results computed in accordance with GAAP. A reconciliation between the historical GAAP and non-GAAP financial measures presented in this release is provided in the financial tables at the end of this release.

About Exponent

Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.

Exponent's consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent's offices in North America, Asia, and Europe. Exponent's consultants, laboratories, databases, and computing resources work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward.

Exponent may be reached at (888) 656-EXPO, [email protected], or www.exponent.com.

Forward Looking Statements

This news release contains, and incorporates by reference, certain “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended) that are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. When used in this document and in the documents incorporated herein by reference, the words “intend,” “anticipate,” “believe,” “estimate,” “expect” and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in generally applicable and industry-specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading “Risk Factors” and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.

Source: Exponent, Inc.

EXPONENT, INC.CONDENSED CONSOLIDATED STATEMENTS OF INCOMEFor the Quarters Ended April 3, 2026 and April 4, 2025(unaudited)(in thousands, except per share data)       Quarters Ended April 3, April 4, 2026
 2025
    Revenues   Revenues before reimbursements
$151,817  $137,437 Reimbursements
 14,486   8,070     Revenues
 166,303   145,507     Operating expenses   Compensation and related expenses
 91,409   75,903 Other operating expenses
 12,825   12,095 Reimbursable expenses
 14,486   8,070 General and administrative expenses
 6,204   5,007     Total operating expenses
 124,924   101,075     Operating income
 41,379   44,432     Other income   Interest income, net
 1,718   2,714 Miscellaneous income (expense), net
 (758)  (9,386)  960   (6,672)    Income before income taxes
 42,339   37,760     Income taxes 12,770   11,110         Net income
$29,569  $26,650         Net income per share:   Basic
$0.59  $0.52 Diluted
$0.59  $0.52     Shares used in per share computations:   Basic
 49,790   51,283 Diluted
 50,119   51,650      EXPONENT, INC.CONDENSED CONSOLIDATED BALANCE SHEETSApril 3, 2026 and January 2, 2026(unaudited)(in thousands)         April 3, January 2, 2026
 2026
Assets   Current assets:   Cash and cash equivalents
$118,553  $221,930 Accounts receivable, net
 197,336   181,507 Prepaid expenses and other assets
 24,999   24,143 Total current assets
 340,888   427,580 Property, equipment and leasehold improvements, net 71,875   71,981 Operating lease right-of-use asset 70,451   73,376 Goodwill 8,607   8,607 Other assets 195,560   195,975 Total assets
$687,381  $777,519     Liabilities and Stockholders' Equity   Current liabilities:   Accounts payable and accrued liabilities
$37,354  $30,942 Accrued payroll and employee benefits
 82,561   121,302 Deferred revenues
 15,568   18,868 Operating lease liability
 6,715   6,890 Total current liabilities
 142,198   178,002 Other liabilities 132,523   133,232 Operating lease liability 74,323   75,944 Total liabilities
 349,044   387,178     Stockholders' equity:   Common stock
 66   66 Additional paid-in capital
 386,329   369,747 Accumulated other comprehensive loss
 (2,571)  (2,290)Retained earnings
 682,013   668,423 Treasury stock, at cost
 (727,500)  (645,605)Total stockholders' equity
 338,337   390,341 Total liabilities & stockholders' equity
$687,381  $777,519      EXPONENT, INC. EBITDA and EBITDAS (1) For the Quarters Ended April 3, 2026 and April 4, 2025(unaudited)(in thousands)         Quarters Ended  April 3, April 4,  2026
 2025
      Net Income$29,569  $26,650       Add back (subtract):         Income taxes
 12,770   11,110  Interest income, net
 (1,718)  (2,714) Depreciation and amortization
 2,515   2,492       EBITDA (1)
 43,136   37,538       Stock-based compensation
 9,058   8,179       EBITDAS (1)
$52,194  $45,717                 (1) EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP.

Exponent, Inc. (EXPO) Q1 2026 Earnings Call Transcript

June 05, 2026 16:05 ET  | Source: Exponent, Inc.

MENLO PARK, Calif., June 05, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that Chief Executive Officer Dr. Catherine Corrigan, President John Pye, Executive Vice President Richard Schlenker, and Chief Financial Officer Eric Anderson will participate in a fireside chat at the following investor conference:

Wells Fargo 16th Annual Industrials & Materials Conference

Date: Tuesday, June 9, 2026Time: 12:00 p.m. Eastern Time / 9:00 a.m. Pacific Time
A webcast of the presentation will be accessible on the investor relations section of the Exponent website, http://www.exponent.com/investors. An archived replay of the webcast will be available following the live event. 

About Exponent

Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.

Exponent's consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent's offices in North America, Asia, and Europe. Exponent's consultants, laboratories, databases, and computing resources work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward.

Exponent may be reached at (888) 656-EXPO, [email protected], or www.exponent.com.